Top 5 Software Startup Investors in Marshall Islands in May 2025

Last updated: May 2025 A list of 5 angel investors and VC (Venture Capital) funds that invest in Software startups based in Marshall islands. We rank investors based on the number of investments they made in Software companies from Marshall islands. We update this investor list every month.

Top 5 Software Startup Investors in Marshall Islands in May 2025

Investor	Software Marshall Islands investments
FHS Capital	1
Encryptus Capital	1
Spicy Capital	1
Fady Hannah-Shmouni, MD FRCPC	1
Triple Gem Capital	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Family Office

Investment focus

Blockchain, SaaS, Sales
Seed, Pre-Seed
Canada, United States, Marshall Islands

Portfolio highlights

FLUUS — FLUUS is an aggregator of fiat to crypto gateways with a crypto ramping network covering emerging. FLUUS allows users to buy, sell, or swap cryptocurrencies and tokens. They aggregate cryptographic services into a single software development kit, connect ramping, exchanging, transactions, and payments, and create a money experience.
Flyby — Flyby is an innovation in last mile delivery with a smart delivery box and technology platform offering tracking and advertising.
Homecare Hub — Homecare Hub assists persons with caregiving needs, such as those with dementia, disability, accident, fall risk, or chronic illness, in avoiding huge institutional nursing facilities, by offering a superior experience in a secure, individualized, inexpensive, small shared care and co-living environment. To help people locate home care servicesthat are reasonably priced, it offers home health care services. With the help of the company's services, customers may locate reliable care for their loved ones in the areas of personal care, companion care, live-in care, home support, and many more.

Encryptus Capital is an Investment Firm focused on Alternative Investments, Cryptocurrency and Blockchain-related projects. The proliferation of Distributed Ledger Technology (DLT) is leading to the formation of new markets and innovative ways of creating value. Therefore, we combine technological advantages with the proven elements of traditionalasset management to reach unlimited investment opportunities.Encryptus Capital was founded in 2019 by Lorenzo Corsetti with the purpose of helping retail investors and financial institutions to navigate in the galaxy of digital assets. Our products and services help our clients build a better financial future through technology-based investment solutions. We believe that inefficiencies in investment strategies arise from insufficient knowledge, and we are here to fill that gap.

Investment focus

Blockchain, Cryptocurrency, Virtual Currency
Pre-Seed
Marshall Islands

Portfolio highlights

FLUUS — FLUUS is an aggregator of fiat to crypto gateways with a crypto ramping network covering emerging. FLUUS allows users to buy, sell, or swap cryptocurrencies and tokens. They aggregate cryptographic services into a single software development kit, connect ramping, exchanging, transactions, and payments, and create a money experience.

Spicy Capital is dedicated to supporting innovative ideas that aim to transform the blockchain sector. They help initiatives from fundraising to success by leveraging our deep experience and industry relationships.

Investment focus

Blockchain, Bitcoin, Cryptocurrency
Seed, Pre-Seed, Series A
Singapore, Saudi Arabia, United States

Portfolio highlights

OpenPad AI — OpenPad - The 1st AI Decentralized Launchpad
Stabble — stabble is a protocol revolutionizing liquidity pools by introducing protocol-managed and arbitrage pools. This allows stabble to tackle critical inefficiencies prevalent within Solana's decentralized exchanges.
Astra Nova — Astra Nova combines AGI gaming innovation, part of Nvidia Inception partnership, backed by Shiba Inu and a community-driven approach to revolutionize the gaming world.

Fady Hannah-Shmouni, MD ABIM FRCPC is an Iraqi-Canadian physician-entrepreneur who specializes in endocrinology, hypertension and genetics. He is a clinical professor of medicine at the University of British Columbia, and an early-stage investor and advisor with over 10 years of clinical and business experience. He has conducted extensive researchin the field of hormones and genetics at America’s research hospital, the National Institutes of Health, and co-founded and financed several startup companies in the fintech, blockchain and healthcare sectors. Business:Fady is the Managing Partner and Co-Founder of FHS Capital (fhscapital.io), a privately held early-stage investment fund focusing on real estate, express car wash services, wellness and digital assets. He serves as a strategic advisor and consultant on several healthTech and blockchain companies, focusing on strategic planning, operational skills, business support, and financing. He led several seed financing rounds, including; Ovenue Inc. (ovenue.com), a no-code AI and blockchain Platform-as-a-Service for real-world asset valuation and tokenization; Flyby (flyby.global), a technology platform connecting last mile delivery with digital out of home advertising; and Fluus (fluus.com), a web3 ramping solution. Medicine:Fady completed clinical training in internal medicine at Yale School of Medicine; adult endocrinology, diabetes and metabolism at the National Institutes of Health; and clinical biochemical genetics at the University of Toronto. He is board-certified in internal medicine and endocrinology by the American Board of Internal Medicine and Royal College of Physician and Surgeons of Canada; and in clinical hypertension by the American Society of Hypertension. He is an active staff physician and adjunct professor at Vancouver General Hospital (UBC), and Trillium Health Partners (UofT), and a fellow with the Royal College of Physicians and Surgeons of Canada. Research: Fady served the NIH (2015-2021) as a physician-scientist in endocrinology/genetics, Head of Graduate Medical Education and Associate Program Director of endocrinology fellowship program. His research interests remain on adrenal disorders including primary aldosteronism, a common cause of hypertension that is potentially reversible with early detection and treatment. He has authored over 100 original articles, book chapters and reviews on endocrine-genetic conditions (h-index 20, i10-index 42), and was the founding member and first Editor-in-Chief of the medical journal Endocrine and Metabolic Science (Elsevier).